Live feed
Filing
SC 13G/A
SC 13G/A0001104659-20-103962·Ascendis Pharma A/S
Schedule 13G ownership disclosure
EIGER BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 28249U105
Event date: 2020-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-103962
- Form type
- SC 13G/A
- Filer
- Ascendis Pharma A/S
- CIK
- CIK 1612042
- Filed
- Sep 10, 2020
- Reporting period
- Mar 31, 2020
- Description
- Schedule 13G beneficial ownership